N-(toluene-4-sulfonyl)-L-(1,1-dioxo-5,5-dimethyl)thiaprolyl-L-4-(N,N-dimethylcarbamyloxy)phenylalanine

ID: ALA3893490

Chembl Id: CHEMBL3893490

PubChem CID: 134137494

Max Phase: Preclinical

Molecular Formula: C25H31N3O9S2

Molecular Weight: 581.67

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1ccc(S(=O)(=O)N2CS(=O)(=O)C(C)(C)[C@@H]2C(=O)N[C@@H](Cc2ccc(OC(=O)N(C)C)cc2)C(=O)O)cc1

Standard InChI:  InChI=1S/C25H31N3O9S2/c1-16-6-12-19(13-7-16)39(35,36)28-15-38(33,34)25(2,3)21(28)22(29)26-20(23(30)31)14-17-8-10-18(11-9-17)37-24(32)27(4)5/h6-13,20-21H,14-15H2,1-5H3,(H,26,29)(H,30,31)/t20-,21-/m0/s1

Standard InChI Key:  FHGHBEJKBMOYTD-SFTDATJTSA-N

Alternative Forms

  1. Parent:

    ALA3893490

    ---

Associated Targets(Human)

ITGAL Tclin Integrin alpha-L/beta-2 (LFA-1) (51 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ITGB1 Tclin Integrin alpha-4/beta-1 (2269 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ITGB1 Tclin ITGB1-ITGA9 complex (10 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 581.67Molecular Weight (Monoisotopic): 581.1502AlogP: 1.39#Rotatable Bonds: 8
Polar Surface Area: 167.46Molecular Species: ACIDHBA: 8HBD: 2
#RO5 Violations: 1HBA (Lipinski): 12HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: 2.92CX Basic pKa: CX LogP: 1.69CX LogD: -1.79
Aromatic Rings: 2Heavy Atoms: 39QED Weighted: 0.47Np Likeness Score: -0.76

References

1.  (2003)  Alpha-9 integrin antagonists and anti-inflammatory compositions therof, 

Source